Intellia Therapeutics, Inc. (NTLA)

NASDAQ: NTLA · Real-Time Price · USD

11.42

-0.33 (-2.81%)

At close: Sep 28, 2026, 4:00 PM EDT

11.49

+0.07 (0.61%)

Pre-market: Sep 29, 2026, 7:47 AM EDT

Intellia Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	59.51	67.67	57.88	36.28	52.12	33.05
Revenue Growth	12.58%	16.92%	59.55%	-30.40%	57.69%	-43.01%
Cost of Revenue	282.32	324.45	406.91	435.07	419.98	229.81
Gross Profit	-222.82	-256.78	-349.04	-398.79	-367.86	-196.75
Selling, General & Admin	200.66	184.21	185.23	116.5	90.31	71.1
Operating Expenses	200.66	184.21	185.23	116.5	90.31	71.1
Operating Income	-423.48	-440.99	-534.26	-515.29	-458.16	-267.85
Interest & Investment Income	24.19	29.2	47.81	49.83	8.54	1.28
Earnings From Equity Investments	-	-	-	-15.63	-11.08	-1.33
EBT Excluding Unusual Items	-399.29	-411.8	-486.46	-481.09	-460.7	-267.89
Gain (Loss) on Sale of Investments	-0.69	-0.9	-32.57	-	-	-
Other Unusual Items	-	-	-	-0.1	-13.49	-
Pretax Income	-399.98	-412.69	-519.02	-481.19	-474.19	-267.89
Net Income	-399.98	-412.69	-519.02	-481.19	-474.19	-267.89
Net Income to Common	-399.98	-412.69	-519.02	-481.19	-474.19	-267.89
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	120	108	99	89	77	71
Shares Outstanding (Diluted)	120	108	99	89	77	71
Shares Change	16.63%	9.64%	11.35%	15.33%	8.57%	26.63%
EPS (Basic)	-3.34	-3.81	-5.25	-5.42	-6.16	-3.78
EPS (Diluted)	-3.34	-3.81	-5.25	-5.42	-6.16	-3.78
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-348.69	-395.87	-354.66	-408.07	-346.85	-237.79
Free Cash Flow Per Share	-2.92	-3.65	-3.59	-4.60	-4.51	-3.35
Operating Margin	-711.66%	-651.67%	-923.10%	-1420.51%	-879.04%	-810.37%
Profit Margin	-672.16%	-609.85%	-896.77%	-1326.51%	-909.78%	-810.49%
Free Cash Flow Margin	-585.97%	-584.99%	-612.78%	-1124.94%	-665.46%	-719.41%
EBITDA	-414.4	-431.22	-523.98	-506.32	-450.59	-260.96
D&A For EBITDA	9.08	9.77	10.29	8.98	7.57	6.89
EBIT	-423.48	-440.99	-534.26	-515.29	-458.16	-267.85

SEC Filings: 10-K · 10-Q